1. Describe the challenge in treating older adults with AML

  2. Understand the state-of-the-art frontline treatment of AML in older adults (outside of HSCT)

  3. Discuss current clinical trials at the University of Chicago aimed at treating older adults with AML



  1. Discuss immunotherapy biomarkers associated with gynecologic malignancies

  2. Review Phase I and II data from checkpoint inhibitor trials in cervical, endometrial and ovarian cancers

  3. Discuss tumor characteristics that may facilitate immunotherapy treatment in these cancers

Session date: 
04/30/2018 - 12:00pm to 1:00pm CDT
5841 South Maryland Avenue
MC2115, Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Benjamin Derman, MD and Padma Sheila Rajagopal, MD